竹子的基因组序列草图
Draft Genome Sequence of Bamboo.
作者信息
Yee Michelle, Klinzing David, Wei Jun-Rong, Gengenbacher Martin, Rubin Eric J, Dick Thomas
机构信息
Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore.
AITbiotech Singapore, Singapore, Republic of Singapore.
出版信息
Genome Announc. 2017 May 18;5(20):e00388-17. doi: 10.1128/genomeA.00388-17.
Abstract
, an intrinsically multidrug-resistant pathogen, causes chronic incurable lung disease. New drugs for this emerging pathogen represent an urgent unmet medical need. Here, we report a draft genome sequence of Bamboo, a clinical isolate used as a screening strain for drug discovery.
摘要
作为一种具有内在多重耐药性的病原体，会引发慢性无法治愈的肺部疾病。针对这种新出现的病原体的新药是一项迫切未满足的医疗需求。在此，我们报告了Bamboo的基因组序列草图，Bamboo是一株用作药物发现筛选菌株的临床分离株。
相似文献
1
Draft Genome Sequence of Bamboo.竹子的基因组序列草图
Genome Announc. 2017 May 18;5(20):e00388-17. doi: 10.1128/genomeA.00388-17.
2
Teicoplanin - Tigecycline Combination Shows Synergy Against .替考拉宁-替加环素联合用药对……显示出协同作用。
Front Microbiol. 2018 May 11;9:932. doi: 10.3389/fmicb.2018.00932. eCollection 2018.
3
Rifabutin Is Active against Mycobacterium abscessus Complex.利福布汀对脓肿分枝杆菌复合群有活性。
Antimicrob Agents Chemother. 2017 May 24;61(6). doi: 10.1128/AAC.00155-17. Print 2017 Jun.
4
Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.用新型水杨酰苯胺酯和氨基甲酸盐对抗高抗性新兴病原体脓肿分枝杆菌和结核分枝杆菌。
Eur J Med Chem. 2015 Aug 28;101:692-704. doi: 10.1016/j.ejmech.2015.07.001. Epub 2015 Jul 7.
5
, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients.铜绿假单胞菌，囊性纤维化患者的新兴且令人担忧的病原体。
Int J Mol Sci. 2019 Nov 22;20(23):5868. doi: 10.3390/ijms20235868.
6
Comparative Analysis of Whole-Genome and Methylome Profiles of a Smooth and a Rough Clinical Strain.光滑型和粗糙型临床株全基因组和甲基组谱的比较分析。
G3 (Bethesda). 2020 Jan 7;10(1):13-22. doi: 10.1534/g3.119.400737.
7
Reporter-Based Assays for High-Throughput Drug Screening against .基于报告基因的高通量药物筛选检测方法 针对……
Front Microbiol. 2017 Nov 10;8:2204. doi: 10.3389/fmicb.2017.02204. eCollection 2017.
8
Whole-Genome Shotgun Sequencing of Mycobacterium abscessus M156, an Emerging Clinical Pathogen in Malaysia.马来西亚新兴临床病原体脓肿分枝杆菌M156的全基因组鸟枪法测序
Genome Announc. 2013 Jan;1(1). doi: 10.1128/genomeA.00063-12. Epub 2013 Jan 15.
9
Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.利福布丁与一线抗分枝杆菌抗生素克拉霉素和替加环素协同作用并具有杀菌作用，提示这是一种有效的治疗组合。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00283-18. Print 2018 Aug.
10
Thiostrepton: A Novel Therapeutic Drug Candidate for Infection.硫链丝菌素：一种新型抗感染治疗候选药物。
Molecules. 2019 Dec 10;24(24):4511. doi: 10.3390/molecules24244511.
引用本文的文献
1
Durlobactam to boost the clinical utility of standard of care β-lactams against lung disease.杜洛巴坦可提高标准护理β-内酰胺类药物对肺部疾病的临床效用。
Antimicrob Agents Chemother. 2025 Jan 31;69(1):e0104624. doi: 10.1128/aac.01046-24. Epub 2024 Nov 20.
2
ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant in caseum surrogate.耐 ADP-核糖基化利福布汀类似物对干酪素替代物中耐药结核分枝杆菌具有增强的杀菌活性。
Antimicrob Agents Chemother. 2023 Sep 19;67(9):e0038123. doi: 10.1128/aac.00381-23. Epub 2023 Jul 26.
3
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatization.拓展抗结核 5-(2-氨基噻唑-4-基)异噁唑-3-甲酰胺的相关知识：基于骨架衍生化的新型抗结核化学型物的从头至先导优化和释放。
Eur J Med Chem. 2023 Jan 5;245(Pt 2):114916. doi: 10.1016/j.ejmech.2022.114916. Epub 2022 Nov 11.
4
Profiling of the Synthetic RNA Polymerase Inhibitor MMV688845 against Mycobacterium abscessus.针对脓肿分枝杆菌的合成 RNA 聚合酶抑制剂 MMV688845 的分析。
Microbiol Spectr. 2022 Dec 21;10(6):e0276022. doi: 10.1128/spectrum.02760-22. Epub 2022 Nov 15.
5
Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus .结核分枝杆菌 DprE1 抑制剂 OPC-167832 对脓肿分枝杆菌有效。
Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0123722. doi: 10.1128/aac.01237-22. Epub 2022 Nov 9.
6
Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease.强烈杀菌的全口服β-内酰胺类药物联合治疗用于治疗脓肿分枝杆菌肺病。
Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0079022. doi: 10.1128/aac.00790-22. Epub 2022 Sep 1.
7
Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus.三环吡咯嘧啶类拓扑异构酶 B 抑制剂对脓肿分枝杆菌的活性。
Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0066922. doi: 10.1128/aac.00669-22. Epub 2022 Aug 25.
8
Structural and Mechanistic Insights into Aspartate Decarboxylase PanD and a Pyrazinoic Acid-Derived Inhibitor.天冬氨酸脱羧酶 PanD 的结构与机制研究及一种吡嗪羧酸衍生抑制剂
ACS Infect Dis. 2022 Jul 8;8(7):1324-1335. doi: 10.1021/acsinfecdis.2c00133. Epub 2022 Jun 22.
9
Anti-Mycobacterium abscessus Activity of Tuberculosis F-ATP Synthase Inhibitor GaMF1.抗脓肿分枝杆菌活性的结核 F-ATP 合酶抑制剂 GaMF1。
Antimicrob Agents Chemother. 2022 May 17;66(5):e0001822. doi: 10.1128/aac.00018-22. Epub 2022 Apr 28.
10
Structure-Activity Relationship of Anti- Piperidine-4-carboxamides, a New Class of NBTI DNA Gyrase Inhibitors.新型NBTI DNA回旋酶抑制剂——抗哌啶-4-羧酰胺的构效关系
ACS Med Chem Lett. 2022 Feb 28;13(3):417-427. doi: 10.1021/acsmedchemlett.1c00549. eCollection 2022 Mar 10.
本文引用的文献
1
Amphiphilic Indole Derivatives as Antimycobacterial Agents: Structure-Activity Relationships and Membrane Targeting Properties.两亲性吲哚衍生物作为抗分枝杆菌药物：构效关系及膜靶向特性
J Med Chem. 2017 Apr 13;60(7):2745-2763. doi: 10.1021/acs.jmedchem.6b01530. Epub 2017 Mar 28.
2
Understanding nontuberculous mycobacterial lung disease: it's been a long time coming.认识非结核分枝杆菌肺病：这一路走来颇费时日。
F1000Res. 2016 Nov 30;5:2797. doi: 10.12688/f1000research.9272.1. eCollection 2016.
3
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.一种可在人际传播的多重耐药非结核分枝杆菌的出现与传播。
Science. 2016 Nov 11;354(6313):751-757. doi: 10.1126/science.aaf8156.
4
Fragment-Based Whole Cell Screen Delivers Hits against M. tuberculosis and Non-tuberculous Mycobacteria.基于片段的全细胞筛选获得针对结核分枝杆菌和非结核分枝杆菌的活性化合物。
Front Microbiol. 2016 Sep 7;7:1392. doi: 10.3389/fmicb.2016.01392. eCollection 2016.
5
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary.美国囊性纤维化基金会和欧洲囊性纤维化协会关于囊性纤维化患者非结核分枝杆菌管理的共识建议：执行摘要
Thorax. 2016 Jan;71(1):88-90. doi: 10.1136/thoraxjnl-2015-207983.
6
Mycobacterium abscessus. "Pleased to meet you, hope you guess my name...".脓肿分枝杆菌。“很高兴见到你，希望你能猜出我的名字……”
Ann Am Thorac Soc. 2015 Mar;12(3):436-9. doi: 10.1513/AnnalsATS.201501-015OI.
7
Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study.全基因组测序鉴定囊性纤维化患者分枝杆菌脓肿之间的传播：一项回顾性队列研究。
Lancet. 2013 May 4;381(9877):1551-60. doi: 10.1016/S0140-6736(13)60632-7. Epub 2013 Mar 29.
8
SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing.SPAdes：一种新的基因组组装算法及其在单细胞测序中的应用
J Comput Biol. 2012 May;19(5):455-77. doi: 10.1089/cmb.2012.0021. Epub 2012 Apr 16.
9
The talking Mycobacterium abscessus blues.会“说话”的脓肿分枝杆菌悲歌
Clin Infect Dis. 2011 Mar 1;52(5):572-4. doi: 10.1093/cid/ciq252.
10
Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.通过 erm(41) 和 rrl 测序评估脓肿分枝杆菌属菌株对克拉霉素的敏感性。
Antimicrob Agents Chemother. 2011 Feb;55(2):775-81. doi: 10.1128/AAC.00861-10. Epub 2010 Dec 6.
Zotero 插件